BioNTech

European Patent Office declares Moderna mRNA patent invalid
European Patent Office declares Moderna mRNA patent invalid
Reuters
Moderna Therapeutics
MRNA
patents
BioNTech
Pfizer
vaccines
Europe
Flag link:
5 Cancer Vaccines to Watch in 2024
5 Cancer Vaccines to Watch in 2024
BioSpace
Merck
Moderna Therapeutics
melanoma
BioNTech
pancreatic cancer
OSE Immunotherapeutics
Transgene
non-small cell lung cancer
Nykode Therapeutics
cervical cancer
Flag link:
Biotheus, BioNTech Partner on Oncology Bispecific Antibody
Biotheus, BioNTech Partner on Oncology Bispecific Antibody
Contract Pharma
BioNTech
bispecific antibodies
Biotheus
Flag link:
BioNTech Stock Jumps On Surprise Profit, Sales Beat
BioNTech Stock Jumps On Surprise Profit, Sales Beat
Investors Business Daily
BioNTech
earnings
COVID-19
Flag link:
Pfizer, BioNTech prep flu-COVID mRNA combo shot for phase 3, reprising Moderna race after seeing early data
Pfizer, BioNTech prep flu-COVID mRNA combo shot for phase 3, reprising Moderna race after seeing early data
Fierce Biotech
Pfizer
BioNTech
Moderna Therapeutics
vaccines
MRNA
flu-COVID combo vaccines
Flag link:
Maternal Covid-19 vaccination offers infants immunity for up to 6 months
Maternal Covid-19 vaccination offers infants immunity for up to 6 months
Stat
COVID-19
vaccines
Pfizer
BioNTech
pregnancy
pediatric
maternal vaccines
Flag link:
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand
Forbes
Pfizer
BioNTech
Moderna Therapeutics
vaccines
COVID-19
Flag link:
BioNTech Inks Potential $1B Deal with MediLink for Cancer-Focused ADCs
BioNTech Inks Potential $1B Deal with MediLink for Cancer-Focused ADCs
BioSpace
BioNTech
MediLink
cancer
antibody-drug conjugate
Flag link:
BioNTech takes another leaf out of Daiichi playbook, paying $70M for HER3-directed ADC
BioNTech takes another leaf out of Daiichi playbook, paying $70M for HER3-directed ADC
Fierce Biotech
BioNTech
Daiichi Sankyo
antibody-drug conjugate
breast cancer
Flag link:
Pfizer resolves Promosome patent lawsuit over COVID-19 vaccine
Pfizer resolves Promosome patent lawsuit over COVID-19 vaccine
Reuters
Pfizer
BioNTech
Promosome
legal
vaccines
MRNA
COVID-19
Flag link:
Why Pfizer and BioNTech Stocks Zoomed Higher Friday
Why Pfizer and BioNTech Stocks Zoomed Higher Friday
Motley Fool
COVID-19
vaccines
Pfizer
BioNTech
Flag link:
CureVac touts 'progress' as German court suspends infringement proceedings against BioNTech
CureVac touts 'progress' as German court suspends infringement proceedings against BioNTech
Fierce Pharma
CureVac
BioNTech
MRNA
patents
legal
Flag link:
mRNA Vaccine Manufacturing Comes to Africa
mRNA Vaccine Manufacturing Comes to Africa
BioSpace
BioNTech
MRNA
vaccines
drug manufacturing
Africa
Rwanda
Flag link:
BioNTech wins up to $90 mln in funding for mpox vaccine development
BioNTech wins up to $90 mln in funding for mpox vaccine development
Yahoo/Reuters
BioNTech
mpox
vaccines
funding
Flag link:
Updated Covid-19 Vaccines Are Here: Will They Help Protect Against Long Covid?
Updated Covid-19 Vaccines Are Here: Will They Help Protect Against Long Covid?
Forbes
FDA
COVID-19
vaccines
boosters
Pfizer
Moderna Therapeutics
BioNTech
Flag link:
Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines
Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines
Fierce Pharma
Pfizer
BioNTech
Moderna Therapeutics
FDA
COVID-19
vaccines
Flag link:
Pfizer and BioNTech’s COVID-19 vaccine for children receives EU recommendation
Pfizer and BioNTech’s COVID-19 vaccine for children receives EU recommendation
Biopharma Reporter
BioNTech
Pfizer
Europe
COVID-19
vaccines
pediatric
Flag link:
Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation
Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation
Fierce Pharma
Pfizer
BioNTech
Moderna Therapeutics
vaccines
MRNA
COVID-19
patents
Flag link:
BioNTech sticks with COVID vaccine outlook amid sharp revenue declines
BioNTech sticks with COVID vaccine outlook amid sharp revenue declines
Medical Marketing and Media
BioNTech
earnings
COVID-19
Flag link:
Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data
Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data
Fierce Biotech
Sanofi
BioNTech
MRNA
cytokines
cancer
Flag link:

Pages